Xilio Therapeutics, Inc. XLO
8.62 USD +0.12 (+1.41%)
At closeNov 6, 2026, 4:00 PM EST
8.77 +0.15 +1.74%
After hours · Nov 6, 4:00 PM ET
8.24 Day range 8.69
7.14 52-week range 11.65
- YTD
- -3.79%
- 1 year
- -26.01%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 43.77M | 6.34M | 0 | 0 | 0 | |
| 43.77M | 6.34M | 0 | 0 | 0 | |
| -41.98M | -60.58M | -79.13M | -89.15M | -75.04M | |
| -35.04M | -58.24M | -76.40M | -88.22M | -75.80M | |
| -4.19 | -15.24 | -38.90 | -45.10 | -189.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 139.34M | 57.07M | 46.29M | 121.95M | 199.61M | |
| 154.69M | 71.08M | 60.93M | 139.16M | 218.06M | |
| 119.41M | 53.48M | 24.10M | 33.52M | 32.63M | |
| 6.95M | 8.14M | 12.50M | 19.94M | 20.54M | |
| 35.27M | 17.60M | 36.83M | 105.65M | 185.43M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -4.99M | -18.38M | -68.62M | -75.72M | -80.75M | |
| -518.00K | -36.00K | -486.00K | -1.87M | -1.10M | |
| 87.78M | 29.20M | -6.55M | -69.00K | 260.67M | |
| -518.00K | -36.00K | -486.00K | -1.87M | -1.10M | |
| 82.27M | 10.78M | -75.66M | -77.66M | 178.82M |